The FDA may take extra time to evaluate the glucagon-related safety signals, particularly the heart rate increase (up to 6.7 bpm above baseline) and dysesthesia (Nature Medicine, 2024)
Patients with pre-existing cardiac conditions , particularly those with heart failure or significant arrhythmias, should be monitored appropriately when initiating GLP-1 receptor agonist therapy
Experts warn those products often lack standardized dosing, consistent manufacturing controls, and robust clinical data
You may be able to recover compensation if: You took Ozempic or another similar weight-loss prescription drug and are no longer using the product You experienced one or more gastrointestinal disorders at least 30 days after your first dose Still have questions
See if GLP-1 is right for you Which GLP-1 is best for weight loss
What separates a strong online GLP-1 program from a mediocre one usually comes down to a few practical things: how transparent the pricing actually is, whether licensed medical providers are genuinely involved, and how much support you get after your first shipment arrives
